Use of sirolimus in the treatment of lymphangioleiomyomatosis: favorable responses in patients with different  extrapulmonary manifestations

Freitas1, Carolina Salim Gonçalves; Baldi2, Bruno Guedes; Araújo1, Mariana Sponholz; Heiden1, Glaucia Itamaro; Kairalla3, Ronaldo Adib; Carvalho4, Carlos Roberto Ribeiro

9450
Views

Back to summary

Open Access

Peer-Reviewed
Série de Casos

Use of sirolimus in the treatment of lymphangioleiomyomatosis: favorable responses in patients with different extrapulmonary manifestations

Uso de sirolimo no tratamento de linfangioleiomiomatose: resposta favorável em pacientes com diferentes manifestações extrapulmonares

Carolina Salim Gonçalves Freitas1, Bruno Guedes Baldi2, Mariana Sponholz Araújo1, Glaucia Itamaro Heiden1, Ronaldo Adib Kairalla3, Carlos Roberto Ribeiro Carvalho4

How to cite this article

Freitas1 CSG, Baldi2 BG, Araújo1 MS, Heiden1 GI, Kairalla3 RA, Carvalho4 CRR. Use of sirolimus in the treatment of lymphangioleiomyomatosis: favorable responses in patients with different extrapulmonary manifestations. J Bras Pneumol. 2015;41(3):275-280